EcoDrugPlus

Sucrase-Isomaltase

Ensembl ID : ENSBBBG00000010878
Gene Symbol: SI
3 Cross references
201 Possible Orthologues:

Synuclein Alpha

Ensembl ID : ENSBBBG00000002027
Gene Symbol: SNCA
3 Cross references
189 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSBBBG00000007280
Gene Symbol: TACR1
3 Cross references
271 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSBBBG00000006029
Gene Symbol: TACR2
3 Cross references
200 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSBBBG00000023533
Gene Symbol: TACR3
3 Cross references
258 Possible Orthologues:

Thromboxane A Synthase 1

Ensembl ID : ENSBBBG00000015965
Gene Symbol: TBXAS1
3 Cross references
219 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSBBBG00000000372
Gene Symbol: TBXA2R
3 Cross references
194 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSBBBG00000021622
Gene Symbol: TYMS
3 Cross references
225 Possible Orthologues:

Thyroid Hormone Receptor Beta

Ensembl ID : ENSBBBG00000011760
Gene Symbol: THRB
3 Cross references
393 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSBBBG00000003115
Gene Symbol: TRHR
3 Cross references
269 Possible Orthologues:

Toll Like Receptor 2

Ensembl ID : ENSBBBG00000014757
Gene Symbol: TLR2
3 Cross references
249 Possible Orthologues:

Toll Like Receptor 4

Ensembl ID : ENSBBBG00000018921
Gene Symbol: TLR4
3 Cross references
127 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).